1 |
OSHA, "Controlling Occupational Exposure to Hazardous Drugs. OSHA Technical Manual(TED 01-00-015). Section VI: Chapter 2", U.S Department of Labor, Occupational Safety & Health Administration. Washington, DC. URL : http://www.osha.gov/dts/ostai/otm/otm vi/otm vi 2.html. 1999
|
2 |
NIOSH, "Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings", National Institute for Occupational
Safety and Health: U.S. Department of Health and Human Services, Public Health Service, Centres for Disease Control and Prevention, 2004-165, 2004
|
3 |
W. Fransman, R. Vermeulen and H. Kromhout, 'Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities', Int Arch Occup Environ Health, Vol. 78, pp. 403-412, 2005
DOI
ScienceOn
|
4 |
Queensland Workplace Health and Safety Strategy,'Guide for handling Cytotoxic Drugs and Related Waste', Department of Industrial Relations, Workplace Health and safety Queensland. Queensland Government; 2005
|
5 |
J. Siderov, 'Is the death knell for cytotoxic manufacturing in hospitals ringing?', J Pharm Prac Res, Vol. 36, p. 78, 2006
|
6 |
S. Crauste-Manciet, PJM. Sessink, S. Ferrari, JY. Jomier, D. Brossard, 'Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators', Ann Occup Hyg, Vol. 49, pp. 619-628,2005
DOI
ScienceOn
|
7 |
E. Ziegler, HJ. Mason, PJ. Baxter, 'Occupational exposure to cytotoxic drugs in the two UKoncology wards', Occup Environ Med, Vol. 59, pp. 608-612, 2002
DOI
ScienceOn
|
8 |
K. Labuhn, B. Valanis, R. Schoeny, K. Loveday, WM. Vollmer, 'Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene and urine mutagenicity tests', Cancer Bursing, Vol. 21, pp. 79-89, 1998
DOI
ScienceOn
|
9 |
CA. Jackson, DA. Wilson, 'World at work: Hospital pharmacy clean-rooms', Occup Environ Med, Vol. 63, pp. 68-70, 2006
DOI
ScienceOn
|
10 |
CL. Ursini, D. Cavallo, A. Colombi, M. Giglio, A. Marinaccio, S. lavicoli, 'Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs', Int Arch Occup Environ Health, Vol. 80, pp.134-140, 2006
DOI
ScienceOn
|
11 |
TH. Connor, PJ. Sessink, BR. Harrison, JR. Pretty, BG. Peters, RM. Alfaro, et al. 'Surface contamination of chemotheraphy drug vials and evaluation of new vial-cleaning techniques: results of three studies', Am J Syst Pharm, Vol. 62, pp. 475-484, 2005
ScienceOn
|
12 |
W. Fransman, R. Vermeulen and H, Kromhout, 'Occupationnal dermal exposure to cyclophosphamide in dutch hospital: a pilot study', Ann Occup Hyg., Vol. 48, pp. 237 -244,2004
DOI
ScienceOn
|
13 |
Authority; 2003, 'Handling Cytotoxic Drugs in the Workplace; Managing Health & Safety Risks Associated with Handling Cytotoxic Drugs in the Healthcare Industry', WorkCover Advisory Service. Worksafe Victoria: Division of the Victorian WorkCover Authority; 2003
|
14 |
P. Gilbar, 'External contamination of antineoplastic agent vials( editorial)', J Pharm PractRes, Vol. 35, pp. 264-265, 2005
DOI
|
15 |
M. Hedmer, A. Georgiadi, R. Bremberg, BAG. Jonsson and S. Eksborg, 'Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden', Ann Occup Hyg, Vol. 49, pp. 629-637, 2005
DOI
ScienceOn
|
16 |
TH. Connor, MA. McDiarmid, 'Preventing occupational exposures to antineoplastic drugs in health care settings, CA Cancer', J Clin, Vol. 56, pp. 354- 365, 2006
DOI
|
17 |
SHPA Committee of Specialty Practice in Oncology, 'SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments', J Pharm Pract Res, Vol. 35, pp. 44-52, 2005
ScienceOn
|
18 |
MG. Jakab, J. Major, A. Tompa, 'Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs', J Toxicol Environ Health A, Vol. 62, pp. 307-318, 2001
DOI
ScienceOn
|
19 |
A. Acapora, L. Castigia, N. Miraglia, M.Pieri, C. Soave, F. Liotti, et aI, 'A case study: Surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals', Ann Occup Hyg. Vol 49, pp. 611-618, 2005
DOI
ScienceOn
|
20 |
PJ. Sessink, Be. Wittenhorst, RB. Anzion, RP. Bos, 'Exposure to pharmacy to antineoplastic agents: reevaluation after additional protective measures', Arch Environ Health, Vol. 52, pp. 240-244, 1997
DOI
ScienceOn
|
21 |
HJ. Mason, S. Blair, e. Sams, K. Jones, SJ. Garfitt, MJ. Cuschieri, et al. 'Exposure to antineoplastic drugs in two UK hospital pharmacy units', Ann Occup Hyg, Vol. 49, pp. 603-610, 2005
DOI
ScienceOn
|
22 |
G. Dranitsaris, M. Johnston, S. Poirier, T. Schueller, D. Milliken, E. Green, B. Zanke, 'Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature', J Oncol Pharm Prac, Vol. II, pp. 69-78,2005
DOI
|
23 |
K. Touzin, JF. Bussieres, E. Langlois, M. Lefebvre, C. Gallant, 'Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficiency of cleaning on vial contamination', Ann. Occup. Hyg,. Vol. 52, No.8, pp. 765-771,2008
DOI
ScienceOn
|